DERMATOLOGÍA PERUANA - VOL. 7, Nº 1, ENERO  -  JUNIO  1997

 

BIBLIOGRAFÍA

1. Espinoza, L. R.: Microbial Superantigens as pathogenic factors. Rheum. Dis. Clin. N. Am. Vol. 19, Febr. 285-86. 1993.

2. Behar, S. M.; Steven, A. P.: Mechanisms of autoinmune disease induction. Arthritis Rheumatism. Vol. 38 Nº. 4 April, 458-76. 1995.

3. Marrack, P.; Kapller, J.: The Staphylococcal Enterotoxines and their relative. Science; 248:705-11. 1990.

4. Lone, S. K.; Ole, B.: Superantigens. Do they have a role in skin disease? Arch. Dermatol. Jul, 131(7): 829-32. 1995.

5. Sisson, J. G.: Superantigens and infections diseases. Lancet Jun. 26;341: 1627-29.1993.

6.Jhonson, H. M.; Russel, J. K.; Ponter, C. H.: Superantigens in human disease. Sc¡. Am. 266:92-101.1992.

7. Dennis, D.; Blank, K. I.: Superantigens and microbial pathogenesis. Ann. Intern. Medicine. 119:89-90.1993.

8. Le Bon, A.; Lucas, B.; Vasseur, F et al: In vivo T Cell response to viral superantigens. J. Inmunol. Jun. 15, 156(12): 4602-8. 1996.

9. Leung-DY.; Travers, J. B.; Norris, D. A.:The role of superantigen in skin disease. J. Invest. Dermatolog. Jul. 105(suppl): 375-425.1995.

10. Smith, T. J.; Terada, N.; Robinson, C. C. et al.: Acute Infectious Monolucleosis stimulates the selective expression/expansion of V-Beta 6.1A and V-Beta 7 T cell. Blood, Vol. 81, No. 6, March, 15:1521-26.1993.

11. Hung, S. C.; Waterbury, G.; Janeway, C. A.: Different superantigens interact with distinct sites in the V beta domain of a single T Cell receptor. J. Exp. Med. Apr. 1, 183(4): 1437-46. 1996.

12. Jhonson, H. M.; Torres, B. A.; Soos, J. M.: Superantigens: structures and relevance to human disease. Proe. Soc. Exp. Biol. Med. Jun. 212(12): 99-109. 1996.

13. Boshell, M.; Me Leod, J.; Walker, L. et al.: Effects of antigen presentation in superantigen induce apoptosis mediates by Fas/Fas Ligand. Ininunnology. Apr. 87(4): 586-92. 1996.

14. Domiati-Saad, R.; Attrep, F.; Breziaschek, H. P. et al.: Staphylococcal Enterotoxin D functions as a human B Cell Superantigen by rescuing VH-4 expression B cell from apoptosis J. Inmunology. May. 15,156(10):3608-20.1996.

15. Rennox, T.; Hahne, M.; Tschopp, J. et al: Peripheral T Cells undergoing superantigen induces apoptosis in vivo express B 220 and upregulate Fas and Pas ligand. J. Exp. Med. Feb. 1, 183(20): 431-7.1996.

16. Pantaleo, G; Stanley, S.: Inmunopathogenic mechanisms of HIV infection. Ann. Intern. Med. 124: 654.1996.

17. Pantaleo, G.; Graziosi, C.; Fauci, A. S.: Comments in the inmununopathogenesis of HIV infection. N. Engl. J. Med. 328:327-35. 1993.

18. Pantaleo, G.; Demarest, J. F.; Soundeyns, H. et al.: Major expansion of CDS+ cells with a predominant V beta usage during the primary inmune response to HIV. Nature. 370:403-7.1994.

19. Bonyhad, M. L.; Robin, L.; Salimi, S. et al.: HIV induce thymus depletion in vivo. Nature. 363:728-32. 1993.

20. Shultz, H.; Geiseihart, A.; Sappler, G. et al.: The Superantigen Staphylococcus Enterotox B induce strong and accelerated secundary T-cell Response rather than anergy. Inmunology. Jan. 87(1):47-54.1996.

21. Mahiknecht, V.; Herter, M.; Hoffmann, M. K.: The Shock Syndrome Toxin-1 induce anergy in human T-cell in vivo. Hum. Inmunology. Jan. 45(1):42-5. 1996.

22. Le Bon, A.; Lucas, B.; Vasstur, F.: In vivo T cell reponse to viral superantigen Selective migration rather than proliferation. J. Imunology. Jun. 15, 156(12):4602. 1996.

23. Cole, B. C.; Knodtdon, K. L.; Oliphant, A.: The sequence of the Mycoplasma Arthritidis Superantingen, (MAM). J. Exp. Med. Mar. 1, 183(3):1105-10.1996.

24. Saloga, J.; Leung, D. Y.; Reardon, C. et al.: Cutaneous exposure to the Superantigen Staphylococuss Enterotoxin B elicits a inflamatory response. J. Invest. Dermatology. May. 106(5):982-8. 1996.

25. Norrby, T.; Eglund, A.; Kaul, R. et al.: Plasma from patients with severe Group A Streptococeal infectious treated with worm polispecific IgG inhibits streptococccal superantigen induce T- cell proliferation and cytokine production. J. Inmunol. Apr. 15,1569:3047-64. 1996.

26. Nickoloff, B. J.; Mitra, R. S.; Green, J. et al.: Accessory cell funtion of keratinocytes for superantigens. J. Inmunology. Vol. 150, Nº. 6. March. 15:2148-59. 1993.

27. Michie, C. A.; Davis, T.: Atopic Dermatitis and Staphylocoecal Superantigens (letter). Lancet. Feb., 3,347(8997): 324. 1996.

28. Schmaltz, R.; Bhogal, B.; Wang, Y. et al.: Staphylococcal Enterotoxin is a bovine T-cell superantigen. Inmunology Invest. Aug. 24(5): 805-18. 1995.

29. Shere, M. T.; Ignatowicz, L.; Pullen, A. et al: The use of Mammary Tumor Virus (MTM) negative and Single-MTV mice to evaluate the effects of Endogenous Viral Superantigen. J. Exp. Med. Nov. 1. 182(5): 1493-504. 1995.

30. Strange, P.; Skov, L.; Lisby, S. et al.: Staphylococcal Enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Areh. Dermatol. Jan. 132(1): 27-33. 1996.

31. Wolf, J. E; Rabinowitz, L. G.: Streptococcal Toxic Shock-Like Syndrome. Arch. Dermatol. Jun. 131(1): 73-7,1995.

32. Tokura, Y.; Yagi, J.; Omalley, M. et al.: Superantigenic Staphycococcal Exotoxins induce keratinocites to produce T-cell activatines citokines. J. Invest. Dermatology. Jan., 102(1): 31-8. 1996.

33. Ducas, M. H.; Taieb, A.; Sarlangue, J. et al.: Cutaneous manifestations of Kawasaki disease. Ann. Dermatolog. Venerol. 120(9): 589-97. 1993.

34. Li, S.; Quayle, A. J.; Thoen, J. E. et al.: Superantigen mediated proliferation and cytotoxity of T-cell isolated from tissues and peripheral blood of arthritic patiens. Clinic Inmunol. Inmunopathol. Jun.

19(3): 278-87. 1996. 1

35. Mallard, I.; Erny, K.; Acha-Orbea, H. et al.: A Vbeta 4-specific superantigen encoded by a new exogenous Mouse Mammary Tumor Virus. Eur. J. Inmunology. May. 26(5):1000. 1996.

36. He, X.; Goronzy, J. J.; Zhong, W. et al.: VH-3-21 Cells scapes from a state of tolerance in Rheumatoid Arthritis and secreted Rheumatoid Factor. Mol. Med.: Nov. 1(70): 768-80. 1995.

37. Levinson, A. I.; Kozlowski, L.; Zheng, Y. et al.: B-Cell Superantigens: definition and potential impact on the inmune response. J Clinic Inmunol. Nov. 15:265-365. 1995.

38. Hubert, B. T.: The role of Superantigens in virus infection. J.Clinic.Inmunol. Nov. 15(6 suppl): 225-55.1995.

39. Leung, D. Y.; Meissner, C.; Fulton, D. et al.: The potential role of Bacterial Superantigens in the, pathogenesis of Kawasaki Syndrome. J. Clinic Ininunol. Nov. 15(6 suppl): 115-75. 1995.

40. Shlievert, P. M.; Bohach, G. A.; Ohlendorf, D. H. et al.: Molecular structure of Staphylococcus and Streptococcus Superantigens. J. Clinic. Inmunol. Nov. 15(6 suppl): 115-175. 1995.

41. Hu, H. L.; Cornwell, W. D.; Rogers, D. et al.: In vivo analysis of a superantigen induced T cell suppressor factor. Cell Inmunol. Feb. 1.167(2):285-922.1996.

42. Baudet, V.; Hurez, V.; Lapeyre, C. et al.: Intravenous inmunoglobulin modulate the expansión of V beta 3 and V beta 17 induced by SEB. Scand. J. Inmunology. Mar. 43(3):277-82. 1996.

43. Youinov, P.; Saraux, A.; Legoff, P. et al.: Superantigens in Autoinmune Disease. Rev. Rheum. Engl. Oct. 62(9491-7. 1995.

44. Scwab, J. H.; Brown, R. R.; Anderle, S. K. et al.: Reactivation of bacterial cell wall. induced arthritis and alteration of T cells by native and mutant superantigen. Ann. Rheum. Dis. Vol. 54: 524. 1995.

45. Zhao, Y. X.; Dahl, A. L.; Oissou, T. et al.: In situ hibridization analysis of synovial. and sistemic cytokine messenger RNA expression in superantigen mediated staphylococcus arthritis. Arthr. and Rheum. Vol 39, No. 6 (June): 959. 1996.

46. Dennis, L.; Stevens, M. D.; Thanner, M. H. et al.: Group A Streptococcal infections and a Toxic Shock -Like Syndrome. N. Engl. J. Med. Vol. 6 (July):1-7.1989.

47. Espinoza, L.: blicrobial superantigens as pathogenic factors. Rheum. Dis. Clin. N. Am. Vol. 19 (May): 285-287.1993.

48. Vanier, L. E.: Studies on peripheral T-Cell deletion and anergy induced by superantigens. J. Exp. Med. 176:37-46. 1992.

49. Leund, D. Y; Meissner, H. C.; Fulton, D. R. et al.: Toxic Shock Syndrome Toxin-Secreting Staphylococcus aureus in Kawasaki syndrome. Lancet. Dec. 4:1385-1387. 1993.

50. Patrick, M.: The role of superantigens in human disease. Curr. Op. Inf. Dis. Vol 8:170-4. 1995.

51. Acharya, K. R.; Passalacqua, E. F.; Jones, E. Y. et al.: Structural basis of superantigen action inferred from crystal structure of Toxic Shock Syndrome Toxin-1. Nature. 367:94-7. 1994.

52. Alan, L.; Bisno, M.; Dennis, L.: Streptococeal infections of skin and soft tissues. N. Engl. J. Med. Jan. 25:240-7. 1996.

53. Syuji, T.; Yogesh, K. A. and Sharyn, M. W.: Intravenous inmunoglobulin contains specific antibodies inhibitory to activation of T Cell by Staphilococcal Toxin Superantigen. J. Clinic Invest.: Vol. 91, Febr. 602-7. 1993.

54. Bejar, S. M.; Porcell, S. A.: The Role of the inmune response to microbial pathogens. Arthr. and Rheum. Vol 38, No.4 (April): 458-76. 1995.

55. Acharya, K. R.; Passalaqua, E. F.; Yones, I. et al.: Structural basis of Toxic Shock Syndrome Toxin--1 Superantigens. Nature. Vol. 367 (January): 94-7.

56. Theodore, S.; Jardestzky, J. H.; Brown, K: Three dimensional structure of a human Class II histocompatibility complexed with superantigens. Nature. Vol. 368 (April) 21:711-8. 1994.

57. Swaminatham, S.; Forey, W.; Pletcher, J. et al.: Crystal structure of Staphylococcal enterotoxin B superantigen Nature. Vol. 359. (October) No. 29:801-6. 1992.

58. Paliard, X.; West, S. G.; Lafferty, J. P. et al.: Evidence of the effeets of a Superantigen in Rheumatoid Arthritis. Science. 253:325-9. 1991.

59. Dennis, S. D.; Taub, D. S.; Blank, J. K.: Superantigen and microbial pathogenesis (editorial) Ann. Int. Med. 119:89-90. 1993.

 

Regresar al Artículo

Regresar